Angiotensin II Blockade and Renal Protection

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|19|17|3033-3042

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.17, 2013-05, pp. : 3033-3042

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Angiotensin II-mediated renal vasoconstriction amenable to 1 -adrenoceptor blockade

By Ke C.   Zimmerman B.G.  

European Journal of Pharmacology, Vol. 284, Iss. 3, 1995-09 ,pp. : 281-288

Elsevier

Access to resources Recommend Favorite

Inhibition of the renin-angiotensin system and cardio-renal protection: focus on losartan and angiotensin receptor blockade

By Parvanova Aneliya   Chiurchiu Carlos   Ruggenenti Piero   Remuzzi Giuseppe  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 11, 2005-09 ,pp. : 1931-1942

Informa Healthcare

Access to resources Recommend Favorite

The role of angiotensin II in hypertension due to adenosine receptors blockade

By Morato M.   Sousa T.   Guimaraes S.   Moura D.   Albino-Teixeira A.  

European Journal of Pharmacology, Vol. 455, Iss. 2, 2002-11 ,pp. : 135-141

Elsevier

Access to resources Recommend Favorite

Angiotensin II blockade may prevent type 2 diabetes mellitus

By  

Inpharma, Vol. 1, Iss. 1511, 2005-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Selective angiotensin II type 1 receptor blockade ameliorates cyclosporine nephrotoxicity

By Padi S.S.V.   Chopra K.  

Pharmacological Research, Vol. 45, Iss. 5, 2002-05 ,pp. : 413-420

Academic Press

Access to resources Recommend Favorite